AmpliMed Home, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities

For further information, please contact:

Chris Richied
Chief Financial OfficerOfficer
AmpliMed Corporation
4380 North Campbell Avenue, Suite 205
Tucson, AZ 85718

Phone: 520.529.1000 / Fax: 520.529.3001